IREN
IREN Limited
There isn't enough reported data to score IREN yet.
JMSB
John Marshall Bancorp, Inc.
JMSB's fundamentals are strong: its operating margin rose 7 points to 49% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect strong earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
JMSB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JMSB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JMSB.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
JMSB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.9x | $18.46 | -20% |
| Forward | 11x | $23.07 | — |
| Current | 12x | $23.07 | — |
| Fair | 13x | $24.76 | +7.3% |
| Expensive | 15x | $27.86 | +21% |
Historical ranges are pointers, not guarantees.
JMSB's PE is in its cheap range at 12x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
JMSB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for JMSB, but weaker profitability.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
JMSB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.09 | +12% |
| Q3 2026 | $1.87 | +33% |
| Q2 2026 | $1.72 | +29% |
| Q1 2026 | $1.58 | +27% |
| Q4 2025 | $1.49 | +24% |
| Q3 2025 | $1.41 | +18% |
JMSB has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
JMSB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.1M | +11% |
| Q2 2026 | $18.8M | +22% |
| Q1 2026 | $16.8M | +15% |
| Q4 2025 | $16.4M | +14% |
| Q3 2025 | $16.3M | +18% |
| Q2 2025 | $15.4M | +22% |
| Q1 2025 | $14.6M | +16% |
| Q4 2024 | $14.3M | +13% |
JMSB's revenue has grown year over year for nine quarters in a row: $18M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 54% | +12 points |
| Q2 2026 | 48% | +5.4 points |
| Q1 2026 | 47% | +4.4 points |
| Q4 2025 | 47% | +4.9 points |
| Q3 2025 | 42% | +3.4 points |
| Q2 2025 | 43% | +2.9 points |
| Q1 2025 | 42% | -0.8 points |
| Q4 2024 | 43% | -3.9 points |
JMSB has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
JMSB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.4M | +522% |
| Q2 2026 | $5M | -32% |
| Q1 2026 | $8.5M | +29% |
| Q4 2025 | $6.9M | +31% |
| Q3 2025 | $1.2M | -9.6% |
| Q2 2025 | $7.4M | -27% |
| Q1 2025 | $6.6M | +6517% |
| Q4 2024 | $5.2M | -1.1% |
JMSB has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
JMSB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +248 shares |
| 1 year | -0.9% | -128K shares |
| 3 years | -0.7% | -98.7K shares |
JMSB has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $2M |
| Q4 2025 | $768,000 |
| Q3 2025 | $294,000 |
| Q2 2025 | $1.3M |
| Q1 2025 | $46,000 |
| Q4 2024 | — |
JMSB spent $3M buying back its own shares over the past year, up 70% from the year before.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
JMSB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.2x | Net Cash |
| Q2 2026 | -2.4x | Net Cash |
| Q1 2026 | -2.3x | Net Cash |
| Q4 2025 | -1.8x | Net Cash |
| Q3 2025 | -3.2x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -3.8x | Net Cash |
| Q4 2024 | -1.9x | Net Cash |
JMSB has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like JMSB.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
JMSB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.2 | Neutral |
| Stochastic | 39.7 | Neutral |
JMSB's weekly RSI is 57 (neutral) and its Stochastic is 40 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
JMSB PE vs Financial Services Sector
| Metric | JMSB | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 5.2% below |
| PE % | 32 | 63 | 31 pts below |
JMSB is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
JMSB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.1 | 0% below |
| 20 week MA | $22.9 | 0.6% above |
| 50 week MA | $21.5 | 7.3% above |
| 100 week MA | $20.0 | 15% above |
| 200 week MA | $20.0 | 16% above |
JMSB has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
JMSB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.5 | $14.2 | -14% |
| 2021 | $14.2 | $19.6 | +38% |
| 2022 | $19.6 | $29.1 | +49% |
| 2023 | $29.1 | $22.6 | -23% |
| 2024 | $22.6 | $20.1 | -11% |
| 2025 | $20.1 | $20.4 | +1.8% |
| 2026 YTD | $20.4 | $23.1 | +13% |
JMSB has the edge over IREN on returns for 2026, with the stronger performance.